Evidence map›Paper›PMID 42131838›Full record

ArticleFrontiers in neurology

Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.

Pietro Annovazzi, Marinella Clerico, Eleonora Cocco, Antonella Conte, Girolama Alessandra Marfia, Marco Salvetti, Valentina Tomassini, Rocco Totaro, Diego Centonze

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Pietro AnnovazziNeuroimmunology Unit, ASST Valle Olona, Gallarate Hospital, Gallarate, VA, Italy.
Marinella ClericoClinical and Biological Sciences Department, University of Torino, Torino, Italy.
Eleonora CoccoMedical Sciences and Public Health Department, University of Cagliari, Cagliari, Italy.
Antonella ConteDepartment of Human Neurosciences, Sapienza University, Rome, Italy.
Girolama Alessandra MarfiaDepartment of Systems Medicine, Tor Vergata University, Rome, Italy.
Marco SalvettiUnit of Neurology, IRCCS Neuromed, Pozzilli, IS, Italy.
Valentina TomassiniDepartment of Neurosciences, Imaging and Clinical Sciences, University G D'Annunzio, Chieti-Pescara, Italy.
Rocco TotaroDemyelinating Disease Center Department of Neurology, San Salvatore Hospital, L'Aquila, Italy.
Diego CentonzeUnit of Neurology, IRCCS Neuromed, Pozzilli, IS, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fneur.2026.1747131.].

Indexed as

algorithms of treatmentlifestyle interventionsnabiximolsSmouldering Diseasespasticity-plus-syndrome

Identifiers

PMID42131838
PMCPMC13164390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.